DelMar Pharmaceuticals

DelMar Pharmaceuticals (DMPI) added this week at $1.27 (purchased 250 shares) after receiving a tip from a friend about a new cancer treatment that could go toe to toe with big pharma companies. DelMar appears to be a good company with great management, and in my opinion, looks to be a takeover candidate. Delmar will be presenting at the American Association of Cancer Research (AACR) Annual Meeting on April 9, 2014. This presentation could be the spark that ignites this firecracker. If nothing else, keep DMPI on your radar.

http://www.marketwatch.com/story/delmar-pharm..._news_stmp